Main Article Content
Transdermal drug delivery is the safest and convenient delivery system for numerous drugs. Different types of transdermal patches are used for specific targeted drug delivery. Conventional transdermal patches have disadvantage that drugs with larger molecular size have difficulty in absorption. Stratum corneum is the primary barrier layer for many drugs permeation. Several methods are employed for the penetration enhancement and successful penetration of many drugs has been observed. The objective of this article is to explore the potential of different formulation based technology advances in this respect. The drug delivery systems are divided into vesicular and non vesicular drug systems like liposomes, hydrogels, dendrimers etc. and then further their individual role in transdermal drug delivery is discussed. These systems act as carrier for both low as well as high molecular weight drugs, thus resulting in improved stability, solubility and effective delivery of drug molecules. This review articles covers the individual role of these delivery systems along with some examples of drugs.
Pandey S, et al. An overview on transdermal drug delivery system. Int Journal of Phr and Chemical Sciences. 2013;2(3).
Sachan R, Bajpai M. Transdermal drug delivery system: A review; 2013.
Wiedersberg S, Guy RH. Transdermal drug delivery: 30+ years of war and still fighting! Journal of Controlled Release; 2014.
Gaikwad AK. Transdermal drug delivery system: Formulation aspects and evaluation. Comprehensive Journal of Pharmaceutical Sciences. 2013;1(1):1-10.
Sharma A, Saini S, Rana A. Transdermal drug delivery system: A review. Skin. 2012;4(15):18-19.
Bharadwaj S, Gupta G, Sharma V. Topical gel: A novel approach for drug delivery. Journal of Chemical, Biological and Physical Sciences. 2012;2(6).
Sharma N, et al. Blooming pharma industry with transdermal drug delivery system. Indo global Journal of pharmaceutical sciences. 2012;2(3):262-278.
Uchegbu IF, Vyas SP. Non-ionic surfactant based vesicles (niosomes) in drug delivery. International Journal of Pharmaceutics. 1998;172(1):33-70.
Rangasamy M, Ayyasamy B, Raju S, Gummadevelly S, Shaik S. Formulation and in vitro evaluation of noisome encapsulated acyclovir. J Pharm Res. 2008;1:163-166.
Zylberberg C, Matosevic S. Pharma-ceutical liposomal drug delivery: A review of new delivery systems and a look at the regulatory landscape. Drug Delivery. 2016;23(9):3319-3329.
Angelico R, et al. Physicochemical and rheological properties of a novel monoolein-based vesicle gel. Soft Matter. 2013;9(3):921-928.
Carboni M, et al. Physicochemical, cytotoxic, and dermal release features of a novel cationic liposome nanocarrier. Advanced healthcare materials. 2013;2(5): 692-701.
Grice JE, et al. Relative uptake of minoxidil into appendages and stratum corneum and permeation through human skin in vitro. Journal of pharmaceutical sciences. 2010;99(2):712-718.
Sivasankar M, KT. Liposomes-the future of of formulation. Int J Res Pharm Chem. 2011;1(2):259-267.
Touitou E, et al. Liposomes as carriers for topical and transdermal delivery. Journal of Pharmaceutical Sciences. 1994;83(9): 1189-1203.
Prasanthi D, Lakshmi P. Vesicles-mechanism of transdermal permeation: A review. Asian J Pharm Clin Res. 2012; 5(1):18-25.
Bakowsky H, et al. Adhesion characteristics and stability assessment of lectin-modified liposomes for site-specific drug delivery. Biochimica et Biophysica Acta (BBA)-Biomembranes. 2008;1778(1): 242-249.
Zaborova O, et al. Structure and properties of complexes of polycationic brushes with anionic liposomes. Polymer Science Series A. 2011;53(11):1019-1025.
Kelly C, Jefferies C, Cryan S-A. Targeted liposomal drug delivery to monocytes and macrophages. Journal of drug delivery. 2011;2011.
Cui Z, et al. Immunostimulation mechanism of LPD nanoparticle as a vaccine carrier. Molecular pharmaceutics. 2005;2(1):22-28.
Heffernan MJ, Murthy N. Polyketal nanoparticles: A new pH-sensitive biodegradable drug delivery vehicle. Bioconjugate Chemistry. 2005;16(6):1340-1342.
Dubey V, et al. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. Journal of controlled release. 2007;123(2):148-154.
Manosroi A, Kongkaneramit L, Manosroi J. Stability and transdermal absorption of topical amphotericin B liposome formulations. International journal of pharmaceutics. 2004;270(1):279-286.
Maestrelli F, et al. Preparation and characterisation of liposomes encapsulating ketoprofen–cyclodextrin complexes for transdermal drug delivery. International journal of pharmaceutics. 2005;298(1):55-67.
Essa EA, Bonner MC, Barry BW. Electrically assisted skin delivery of liposomal estradiol; phospholipid as damage retardant. Journal of controlled release. 2004;95(3):535-546.
Mura P, et al. Development, characterization and in vivo evaluation of benzocaine-loaded liposomes. European Journal of Pharmaceutics and Biop-harmaceutics. 2007;67(1):86-95.
Kumar KP, Radhika P, Sivakumar T. Ethosomes-a priority in transdermal drug delivery. International Journal of Advances in Pharmaceutical Sciences. 2011;1(2).
Dubey V, Mishra D, Jain NK, Dutta T, Nahar M, Saraf DK. T.D.D of antipsychotic agent via ethanolic liposomes. Journal of controlled release. 2007;123:148-154.
Gangwar S, Shivani S., Garg G. Ethosomes: A novel tool for drug delivery through the skin. Journal of Pharmacy Research. 2010;3(4):688-691.
Touitou E. et al. Ethosomes—novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. Journal of Controlled Release. 2000;65(3):403-418.
Jain S, Umamaheshwari RB, Bhadra D, Jain NK. Ethosomes: A novel vesicular carrier for enhanced transdermal delivery of an anti-HIV agent. Ind J Pharma Sci. 2004;66:72-81.
Ainbinder D, Touitou E. Testosterone ethosomes for enhanced transdermal delivery. Drug delivery. 2005;12(5):297-303.
Godin B, Touitou E. Erythromycin ethosomal systems: Physicochemical characterization and enhanced antibacterial activity. Current drug delivery. 2005;2(3):269-275.
Dayan N, Touitou E. Carriers for skin delivery of trihexyphenidyl HCl: Ethosomes vs. liposomes. Biomaterials. 2000;21(18): 1879-1885.
Verma D, Fahr A. Synergistic penetration enhancement effect of ethanol and phospholipids on the topical delivery of cyclosporin A. Journal of controlled release. 2004;97(1):55-66.
Paolino, D, et al. Innovative drug delivery systems for the administration of natural compounds. Current Bioactive Compounds. 2007;3(4):262-277.
Abdulbaqi IM, et al. Transethosomal gels as carriers for the transdermal delivery of colchicine: Statistical optimization, characterization, and ex vivo evaluation. Drug Design, Development And Therapy. 2018;12:795.
Zheng W-S, et al. Preparation and quality assessment of itraconazole transfersomes. International Journal of Pharmaceutics. 2012;436(1):291-298.
van den Bergh BA, et al. Elasticity of vesicles assessed by electron spin resonance, electron microscopy and extrusion measurements. International Journal of Pharmaceutics. 2001;217(1):13-24.
Vinod KR, et al. Critical issues related to transfersomes–novel vesicular system. Acta Sci Pol Technol Aliment. 2012;11(1):67-82.
Cevc G, Schätzlein A, Richardsen H. Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. Biochimica et Biophysica Acta (BBA)-Biomembranes. 2002;1564(1): 21-30.
Dubey V, et al. Transdermal delivery of a pineal hormone: melatonin via elastic liposomes. Biomaterials. 2006;27(18): 3491-3496.
Chaudhary H, et al. Optimization and formulation design of gels of Diclofenac and Curcumin for transdermal drug delivery by Box‐Behnken statistical design. Journal of pharmaceutical sciences. 2011;100(2):580-593.
Qiu Y, et al. Enhancement of skin permeation of docetaxel: A novel approach combining microneedle and elastic liposomes. Journal of Controlled Release. 2008;129(2):144-150.
Gillet A, et al. Development of a new topical system: drug-in-cyclodextrin-in-deformable liposome. International Journal of Pharmaceutics. 2009;380(1):174-180.
Taghizadeh SM, Bajgholi S. A new Liposomal-Drug-in-adhesive patch for transdermal delivery of sodium diclofenac. Journal of Biomaterials and Nano-biotechnology. 2011;2:576.
Zaru M, et al. Glycerosomes and use thereof in pharmaceutical and cosmetic preparations for topical applications. Google Patents; 2010.
Zaru M, Manca ML, Fadda AM, Orsini G. Glycerosomes and use thereofin pharmaceutical and cosmetic preparations for topical applications. Europe; 2010.
Zaru M, Manca ML, Fadda AM, Orsini G. Glycerosomes and use thereof inpharmaceutical and cosmetic preparations for topical applications. Japan; 2011.
Zaru M, Manca ML, Fadda AM, Orsini G. Glycerosomes and use thereof inpharmaceutical and cosmetic preparations for topical applications. ITA; 2013.
Türker S, Erdo˘gan S, Özer YA, Bilgili H, Deveci S. Enhanced efficacyof diclofenac sodium-loaded lipogelosome formulation in intra-articular treat-ment of rheumatoid arthritis. J. Drug Target. 2008;16:51-57.
Manca ML, et al. Glycerosomes: A new tool for effective dermal and transdermal drug delivery. International journal of pharmaceutics. 2013;455(1):66-74.
Lankaldapalli S, Damuluri M. Sphingosomes: applications in targeted drug delivery. Int J Pharm Chem Biol Sci. 2012;2(4):507-516.
Ashok K, Rajendra Kumar A, Nama S, Brahmaiah B, Desu PK, Rao CB. Sphingosomes: A novel vesicular drug delivery system. International Journal of Pharmaceutical Research and Bio-Science. 2013;2:305-312.
Saraf S, et al. Sphingosomes a novel approach to vesicular drug delivery. Int J Cur Sci Res. 2011;1(2):63-68.
Jain NK. Conrolled and novel drug delivery. CBS publishers and distributors, New Dehli; 2001.
Rajkamal M, SA, Sandeep A. Exploring potential of ufasomes as topical/transdermal delivery systems: reviewing decades of research. American Journal of Pharma Tech Research. 2012;2(1):12.
Mittal R, Sharma A, Arora S. Ufasomes Mediated Cutaneous Delivery of Dexamethasone: Formulation and Evaluation of Anti-Inflammatory Activity by Carrageenin-Induced Rat Paw Edema Model. Journal of Pharmaceutics. 2013; 2013.
Sharma A, Arora S. Formulation and in vitro evaluation of ufasomes for dermal administration of methotrexate. International Scholarly Research Notices. 2012;2012.
Keservani RK, Sharma AK, Ramteke S. Novel vesicular approach for topical delivery of baclofen via niosomes. Latin American Journal of Pharmacy. 2010;29.
Muzzalupo R, et al. A new approach for the evaluation of niosomes as effective transdermal drug delivery systems. European Journal of Pharmaceutics and Biopharmaceutics. 2011;79(1):28-35.
Guinedi AS, et al. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. International Journal of Pharmaceutics. 2005;306(1):71-82.
Balakrishnan P, et al. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. International Journal of Pharmaceutics. 2009;377(1):1-8.
Junyaprasert VB, et al. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid. International Journal of Pharmaceutics. 2012;423(2):303-311.
Aziz DE, Abdelbary AA, Elassasy AI. Implementing central composite design for developing transdermal diacerein-loaded niosomes: Ex vivo permeation and in vivo deposition. Current Drug Delivery. 2018;15(9):1330-1342.
Jatav VS, Singh H, Singh SK. Recent trends on hydrogel in human body. Change. 2011;13:15.
Lin C-C, Metters AT. Hydrogels in controlled release formulations: network design and mathematical modeling. Advanced Drug Delivery Reviews. 2006;58(12):1379-1408.
BSV M, Chattergee A, Arkendu. As a review on hydrogels as drug delivery in the pharmaceutical field. International Journal of Pharmaceutical and Chemical Sciences. 2012;1(2):642-661.
Sahu NK, et al. ISSN 2277–7164 Biodegradable Hydrogels in Controlled Drug Delivery; 2012.
Mazzitelli S, et al. Hydrogel blends with adjustable properties as patches for transdermal delivery. International Journal of Pharmaceutics. 2013;454(1):47-57.
Sun Y, et al. Transdermal delivery of the in situ hydrogels of curcumin and its inclusion complexes of hydroxypropyl-β-cyclodextrin for melanoma treatment. International Journal of Pharmaceutics. 2014;469(1):31-39.
Ibrahim MM, Hafez SA, Mahdy MM. Organogels, hydrogels and bigels as transdermal delivery systems for diltiazem hydrochloride. Asian Journal of Pharmaceutical Sciences. 2013;8(1):48-57.
Dwivedi DK, Singh A.K. Dendrimers: A novel carrier system for drug delivery. Journal of Drug Delivery and Therapeutics. 2014;4(5):1-6.
Babu VR, et al. Dendrimers: A New Carrier System for Drug Delivery. Int J Pharma Applied Sci. 2010;1:1-10.
Twibanire JDAK, Grindley TB. Polyester Dendrimers: Smart Carriers for Drug Delivery. Polymers. 2014;6(1):179-213.
Prianka VK, Prajapati SN, Prajapati R. A review on applications of dendrimers in transdermal drug delivery. International Research Journal of Pharmacy. 2012; 3(11):35-39.
Filipowicz A, Wołowiec S. Solubility and in vitro transdermal diffusion of riboflavin assisted by PAMAM dendrimers. International Journal of Pharmaceutics. 2011;408(1):152-156.
Borowska K, et al. Transdermal delivery of 8-methoxypsoralene mediated by polyamidoamine dendrimer G2. 5 and G3. 5—In vitro and in vivo study. International Journal of Pharmaceutics. 2012;436(1): 764-770.
Muzaffar F, Singh U, Chauhan L. Review on microemulsion as futuristic drug delivery. Int J Pharmacy Pharmaceutical Sci. 2013;5:39-53.
Tavano L. et al. Niosomes< i> vs microemulsions: New carriers for topical delivery of Capsaicin. Colloids and Surfaces B: Biointerfaces. 2011;87(2):333-339.
Fanun M. Microemulsions as delivery systems. Current Opinion in Colloid & Interface Science. 2012;17(5):306-313.
Lu W-C, et al. Skin permeation of d-limonene-based nanoemulsions as a transdermal carrier prepared by ultrasonic emulsification. Ultrasonics sonochemistry. 2014;21(2):826-832.
Kogan A, Garti N. Microemulsions as transdermal drug delivery vehicles. Advances in Colloid and Interface Science. 2006;123:369-385.
Lopes LB. Overcoming the Cutaneous Barrier with Microemulsions. Pharmaceutics. 2014;6(1):52-77.
Hoppel M, et al. Effect of monoacyl phosphatidylcholine content on the formation of microemulsions and the dermal delivery of flufenamic acid. International Journal of Pharmaceutics; 2014.
Kalaitzaki A, et al. Surfactant-rich biocompatible microemulsions as effective carriers of methylxanthine drugs. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2014;442:80-87.
Zhao L, et al. Ropivacaine loaded microemulsion and microemulsion-based gel for transdermal delivery: Preparation, optimization, and evaluation. International Journal of Pharmaceutics. 2014;477(1):47-56.
Mura P, et al. Development of liposomal and microemulsion formulations for transdermal delivery of clonazepam: Effect of randomly methylated β-cyclodextrin. International Journal of Pharmaceutics. 2014;475(1):306-314.
Hathout RM, Nasr M. Transdermal delivery of betahistine hydrochloride using microemulsions: Physical characterization, biophysical assessment, confocal imaging and permeation studies. Colloids and Surfaces B: Biointerfaces. 2013;110:254-260.
Fouad SA, et al. Microemulsion and poloxamer microemulsion-based gel for sustained transdermal delivery of diclofenac epolamine using in-skin drug depot: in vitro/in vivo evaluation. International Journal of Pharmaceutics. 2013;453(2):569-578.
Liu C-H, Chang F-Y, Hung D-K. Terpene microemulsions for transdermal curcumin delivery: effects of terpenes and cosurfactants. Colloids and Surfaces B: Biointerfaces. 2011;82(1):63-70.
Gattani Y. Floating multiparticulate drug delivery systems: An overview. International Journal of Pharma & Bio Sciences. 2010;1(2).
Kumar BP, et al. Microparticulate Drug Delivery System: A Review. Indian Journal of Pharmaceutical Science & Research. 2011;1(1):19-37.
Kumar M. Nano and microparticles as controlled drug delivery devices. J. Pharm. Pharm. Sci. 2000;3(2):234-258.
Parida KR, et al. Microparticles Based Drug Delivery Systems: Preparation and Application in Cancer Therapeutics. Cellulose. 2013;17:18.
Prow TW, et al. Nanoparticles and microparticles for skin drug delivery. Advanced Drug Delivery Reviews. 2011;63(6):470-491.
Palmer BC, DeLouise LA. Nanoparticle-enabled transdermal drug delivery systems for enhanced dose control and tissue targeting. Molecules. 2016;21(12): 1719.
Neubert RH. Potentials of new nanocarriers for dermal and transdermal drug delivery. European Journal of Pharmaceutics and Biopharmaceutics. 2011;77(1):1-2.
Tarek AA, Khalid ME-S. Development of alginate-reinforced chitosan nanoparticles utilizing W/O nanoemulsification/internal crosslinking technique for transdermal delivery of rabeprazole. Journal of life sciences. 2014;110:35-43.
Khalil SK, et al. Preparation and evaluation of warfarin-β-cyclodextrin loaded chitosan nanoparticles for transdermal delivery. Carbohydrate Polymers. 2012;90(3):1244-1253.
Lam P-L, et al. Development of hydrocortisone succinic acid/and 5-fluorouracil/chitosan microcapsules for oral and topical drug deliveries. Bioorganic & Medicinal Chemistry Letters. 2012;22(9): 3213-3218.
Santander-Ortega M, et al. Nanoparticles made from novel starch derivatives for transdermal drug delivery. Journal of Controlled Release. 2010;141(1): 85-92.
Sharma N, et al. A review: Transdermal drug delivery system: A tool for novel drug delivery system. International Journal of Drug Development & Research. 2011;3(3):70-84.
Jhawat VC, et al. Transdermal drug delivery systems: approaches and advancements in drug absorption through skin. Int J Pharm Sci Rev Res. 2013;20:47-56.